ANDREA HARRIS: Open Payments
NPI 1801145776 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 20 payments from 9 companies in 2025. Trend: 2023 $178 · 2024 $323 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $122 |
| Amgen Inc. | 1 | $49 |
| Indivior Inc. | 3 | $46 |
| Alkermes, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: VRAYLAR, KRYSTEXXA, SUBLOCADE, ARISTADA, CAPLYTA, INVEGA SUSTENNA, Auvelity, HETLIOZ.
Industry payments across IA — which companies pay providers there.
